Note: Ingredients listed on restricted chemical lists
EC/CAS
215-175-0/1309-64-4
Name of the chemical
Diantimontrioxid
Concentration
051-005-
General Information
Version
7.0 en
Revision date
2025-08-04
Product name
Antimony(III) oxide ≥95 %, extra pure
CAS No.
1309-64-4
REACH No
01-2119475613-35-xxxx
1.2.2. Uses advised against
Do not use for products which come into contact with foodstuffs. Do not use for private purposes (household). Food, drink and animal feeding- stuffs
Icons in SDS
Company Information
company name
Carl Roth GmbH + Co. KG
e-mail address of the competent person responsible for the Safety Data Sheet
sicherheit@carlroth.de
GHS Information
Signal word
Not required
Hazard Codes
Hazard statements (CLP)
H351
Hazard statements
Code
Statements
H351
Suspected of causing cancer
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No 1272/2008 [CLP Classification of the substance or mixture
Hazard categories
Cat- Hazard class and Hazard egory category statement 3.6 Carcinogenicity Carc. 2 H351 For full text of abbreviations: see SECTION 16
Signal word
Warning Not required
Hazard pictograms
GHS08 H351 Suspected of causing cancer. P280 Wear protective gloves/eye protection. P308+P313 IF exposed or concerned: Get medical advice/attention. Labelling of packages where the contents do not exceed 10 ml
Hazard statements
H351 Suspected of causing cancer Not required
Prevention
P280 Wear protective gloves/eye protection
Response
P308+P313 IF exposed or concerned: Get medical advice/attention For professional users only Labelling of packages where the contents do not exceed 125 ml
Precautionary statements
Not required
Results of PBT and vPvB assessment
According to the results of its assessment, this substance is not a PBT or a vPvB. Endocrine disrupting properties Does not contain an endocrine disruptor (ED) at a concentration of ≥ 0,1%.
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 (CLP) Section Hazard class Cat- Hazard class and Hazard egory category statement 3.6 Carcinogenicity 2 Carc. 2 H351 For full text of abbreviations: see SECTION 16
